San Francisco Sentry Investment Group’s Elevance Health ELV Stock Holding History

San Francisco Sentry Investment Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$253K	Hold	665	–	–	0.13%	174
2021 Q1	$239K	Buy	665 +75	+13%	+$24.1K	0.1%	199
2020 Q4	$190K	Buy	590 +80	+16%	+$24.6K	0.09%	206
2020 Q3	$137K	Buy	510 +60	+13%	+$16.1K	0.07%	228
2020 Q2	$118K	Buy	450 +389	+638%	+$104K	0.06%	239
2020 Q1	$14K	Sell	61 -3	-5%	-$818	0.01%	424
2019 Q4	$19K	Buy	64 +3	+5%	+$826	0.01%	492
2019 Q3	$14K	Sell	61 -12	-16%	-$3.29K	0.01%	522
2019 Q2	$20K	Sell	73 -13	-15%	-$3.55K	0.01%	479
2019 Q1	$24K	Buy	86 +3	+4%	+$868	0.01%	475
2018 Q4	$22K	Sell	83 -2	-2%	-$550	0.01%	464
2018 Q3	$23K	Buy	85 +55	+183%	+$14.3K	0.01%	487
2018 Q2	$7K	Sell	30 -4,000	-99%	-$926K	﹤0.01%	590
2018 Q1	$886K	Sell	4,030 -69	-2%	-$16.2K	0.25%	80
2017 Q4	$923K	Sell	4,099 -22	-0.5%	-$4.69K	0.27%	79
2017 Q3	$783K	Sell	4,121 -2	-0%	-$381	0.26%	93
2017 Q2	$777K	Sell	4,123 -1	-0%	-$180	0.28%	88
2017 Q1	$682K	Sell	4,124 -1,272	-24%	-$202K	0.38%	78
2016 Q4	$776K	Sell	5,396 -30	-0.6%	-$4.02K	0.45%	67
2016 Q3	$680K	Buy	5,426 +71	+1%	+$9.17K	0.4%	75
2016 Q2	$703K	Hold	5,355	–	–	0.43%	72
2016 Q1	$744K	Hold	5,355	–	–	0.45%	64
2015 Q4	$747K	Buy	5,355 +4	+0.1%	+$551	0.47%	62
2015 Q3	$749K	Buy	5,351 +4	+0.1%	+$601	0.53%	58
2015 Q2	$878K	Buy	5,347 +28	+0.5%	+$4.47K	0.53%	58
2015 Q1	$821K	Sell	5,319 -734	-12%	-$105K	0.49%	61
2014 Q4	$761K	Buy	6,053 +4	+0.1%	+$494	0.44%	63
2014 Q3	$724K	Hold	6,049	–	–	0.36%	71
2014 Q2	$651K	Buy	6,049 +11	+0.2%	+$1.13K	0.31%	79
2014 Q1	$601K	Buy	6,038 +12	+0.2%	+$1.08K	0.19%	116
2013 Q4	$557K	Hold	6,026	–	–	0.19%	117
2013 Q3	$504K	Buy	6,026 +3	+0%	+$257	0.19%	120
2013 Q2	$493K	Buy	+6,023	New	+$451K	0.18%	117

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

San Francisco Sentry Investment Group's ELV Position: Q2 2021 in Review

San Francisco Sentry Investment Group held its Elevance Health (ELV) position steady in Q2 2021 at 665 shares worth $253K. The position accounts for 0.13% of the portfolio, ranked #174.

San Francisco Sentry Investment Group first reported a position in ELV in Q2 2013 and has held it in 33 quarters since. The position peaked at $923K in Q4 2017. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

San Francisco Sentry Investment Group held 665 shares of Elevance Health worth $253K as of Q2 2021.
San Francisco Sentry Investment Group left its Elevance Health share count unchanged in Q2 2021.
Elevance Health made up 0.13% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #174 holding.
San Francisco Sentry Investment Group first reported a position in Elevance Health in Q2 2013 and has held it in 33 quarters since.
San Francisco Sentry Investment Group's Elevance Health position peaked at $923K in Q4 2017.
1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.